Nitric Oxide and Related Aspects Underlying Angina

Area of Science:

• Cardiovascular Physiology
• Metabolic Disorders
• Molecular Signaling

Background:

• Metabolic syndrome (MS) affects a growing patient population, necessitating a deeper understanding of its underlying molecular mechanisms.
• Nitric Oxide (NO) plays a crucial role in various aspects of MS, including cardiovascular diseases, symptoms, and comorbidities.
• Existing literature separately describes NO's involvement in hypertension, ischemia, and pain signaling, but its direct link to cardiovascular symptoms like angina in MS is underexplored.

Purpose of the Study:

• To elucidate the specific alterations in Nitric Oxide (NO) pathways within the context of metabolic syndrome (MS).
• To establish a clearer connection between NO dysregulation and the manifestation of cardiovascular symptoms, particularly angina, in MS.
• To consolidate existing knowledge and highlight research gaps regarding NO's role in MS-related cardiovascular complications.

Main Methods:

• Comprehensive literature review of studies investigating metabolic syndrome, nitric oxide (NO), and cardiovascular symptoms.
• Analysis of research linking NO, nitric oxide synthase (NOS), and related enzymatic pathways to cardiovascular pathologies.
• Synthesis of data on NO's role in hypertension, ischemia, pain signaling, and angina within the framework of MS.

Main Results:

• Nitric Oxide (NO) and its synthesis pathways are integral to the pathophysiology of metabolic syndrome (MS) and its associated cardiovascular diseases.
• Evidence suggests shared signaling pathways between NO, hypertension, ischemia, and pain, which likely contribute to cardiovascular symptoms such as angina.
• Despite the known roles of NO in cardiovascular health, its specific alterations and direct contribution to angina in MS patients remain incompletely understood.

Conclusions:

• Nitric Oxide (NO) dysregulation is a significant factor in the development of cardiovascular symptoms, including angina, within metabolic syndrome (MS).
• Further research is warranted to fully delineate the complex interactions between NO pathways and cardiovascular manifestations in MS.
• Understanding these NO-related mechanisms is crucial for developing targeted therapies for cardiovascular complications in metabolic syndrome.